Valeant Pharmaceuticals, which is currently being questioned by Congress and investigated by federal law enforcement agencies for allegedly buying old drugs and raising their prices, has added three new members to its board: Stephen Fraidin, vice chairman of Pershing...
McKesson has signed official papers to purchase Vantage Oncology in a 1.2 billion dollar transaction. With this development, McKesson will acquire “more than 50 cancer centers across thirteen states.” Paul Julian, the executive vice president and group president of...
